Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) reported Q2 FFO of $0.00, $0.55 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $42.97 million versus the consensus estimate of $37.46 million.

For earnings history and earnings-related data on Sabra Healthcare REIT, Inc. (SBRA) click here.